Evaluation and Management of Abnormal Uterine Bleeding in Women Over Age 45
All women over age 45 with abnormal uterine bleeding require endometrial tissue sampling to exclude endometrial cancer, regardless of imaging findings. 1
Initial Diagnostic Approach
Step 1: Endometrial Biopsy (Mandatory)
- Perform endometrial biopsy in ALL women >45 years with abnormal bleeding 1
- This is non-negotiable due to endometrial cancer risk
- One in 4 endometrial cancers occur in premenopausal women 2
- Do not delay biopsy based on imaging results
Step 2: Transvaginal Ultrasound (First-Line Imaging)
Perform transvaginal ultrasound (TVUS) combined with transabdominal approach as the initial imaging study 3:
Key measurements and findings:
- Postmenopausal women: Endometrial thickness ≥5 mm requires tissue sampling 3
- Thickness <4 mm has nearly 100% negative predictive value for cancer 3
- Premenopausal women: No validated thickness cutoff exists; endometrial pathology can occur even with thickness <5 mm 3
- Assess for structural causes: leiomyomas, adenomyosis, polyps
- Evaluate endometrial echogenicity and texture (abnormalities correlate with pathology) 3
TVUS diagnostic capabilities:
- Sensitivity/specificity for adenomyosis: 82.5%/84.6% 3
- Cannot reliably determine etiology of endometrial thickening 3
- Limited by patient body habitus, uterine position, and presence of fibroids 3
Step 3: Sonohysterography (If Needed)
Use saline-infusion sonohysterography when 3:
- Initial TVUS shows focal endometrial abnormality
- Endometrium inadequately visualized on TVUS
- Further characterization needed
- Technique: transcervical injection of sterile saline with TVUS
- Helps identify endometrial polyps (vascular pedicle has 62-98% specificity) 3
Advanced Imaging (When Initial Studies Inconclusive)
MRI Pelvis with Gadolinium
Consider MRI when 3:
- Uterus incompletely visualized by ultrasound
- Ultrasound findings indeterminate
- Need to differentiate benign from malignant pathology
MRI performance:
- Sensitivity/specificity for endometrial cancer: 79%/89% 3
- Sensitivity/specificity for leiomyosarcoma: 100%/100% 3
- Sensitivity/specificity for adenomyosis: 78%/93% 3
- Include diffusion-weighted sequences (abnormal signal helps differentiate benign from malignant) 3
CT pelvis has no role in AUB evaluation 3
Critical Pitfalls to Avoid
Never skip endometrial sampling in women >45 years based on reassuring ultrasound alone - even thin endometrium can harbor pathology in premenopausal women 3
Do not rely on endometrial thickness in premenopausal women - no validated cutoff exists, and polyps/cancer can occur with any thickness 3
Recognize TVUS limitations - coexisting leiomyomas reduce adenomyosis detection sensitivity from 97.8% to 33.3% 3
If initial biopsy and imaging negative but bleeding persists - repeat TVUS and consider repeat sampling, as cancers can be missed initially 3
Management Considerations
After establishing diagnosis through tissue sampling and imaging:
- Structural lesions (polyps, fibroids, adenomyosis) may require surgical intervention
- Non-structural causes respond to medical therapy (hormonal contraceptives, progestin IUD, tranexamic acid, NSAIDs) 1
- Hysteroscopy with directed biopsy indicated for focal abnormalities 4
The algorithm prioritizes cancer exclusion first (tissue diagnosis), then structural evaluation (imaging), recognizing that endometrial cancer is the most serious etiology in this age group and must be ruled out before pursuing other management strategies 3, 1.